| ★ | Avapritinib's 4-Year Impact on Quality of Life in ISM | Thanai Pongdee, MD | | 73 | Estados Unidos | |
| 11 | GIST Side Effects: What to Expect & How to Manage Them | Strube Stiftung @strubestiftung | 9.0K | Alemania | 84 |
| 19 | LIVE CHEMOTHERAPY AT THE HOSPITAL | Just passing the time | Stage 4 Cancer Update | bignoknow - Noah Thomas @bignoknow | 6.8K | Estados Unidos | 84 |
| 20 | Precision Mold Detoxification with Beth O'Hara, Functional Naturopath | Hawthorn University @hawthornuniversity | 587 | — | 84 |
| 14 | Prévention des récidives de MTEV : impact d’un traitement prolongé par apixaban dans l'étude HI-PRO | Cardio-online @cardio-online9873 | 581 | Francia | 84 |
| 17 | Utilizzare il sistema immunitario per combattere il cancro ha cambiato per sempre la cura dei tumori | MedicinaInformazione @medicinainformazione | 426 | Italia | 84 |
| 3 | Patient Perspectives on a Potential New Dermatomyositis Therapy: Insights from Phase 3 VALOR Trial | The Myositis Association (TMA) @myositisassociation | 371 | Estados Unidos | 86 |
| 12 | NUOVE CURE PER IL CANCRO: IMMUNOTERAPIA MIGLIORA PROGNOSI E QUALITA' VITA IN FASE PRECOCE E AVANZATA | MedicinaInformazione @medicinainformazione | 298 | Italia | 84 |
| 16 | Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 84 |
| 9 | Provider Connections: Dr. Saad Kenderian on Updates in CAR-T Therapy in Chronic Lymphocytic Leukemia | | 228 | Estados Unidos | 84 |
| 7 | Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | 84 |
| 8 | Functional Cures for T1D: Insulin Independence Through Islet Transplantation | | 185 | Estados Unidos | 84 |
| 6 | Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes | | 143 | Estados Unidos | 84 |
| 5 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 85 |
| 13 | Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care | | 59 | Estados Unidos | 84 |
| 4 | Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More | EAC 2026 | | 58 | Estados Unidos | 85 |
| 18 | Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients | | 53 | Estados Unidos | 84 |
| 10 | Presentació del Quadern de la Bona Praxi 'Teràpies no validades o fora de fitxa tècnica' | Consell de Col·legis de Metges de Catalunya @ccmc_metgescatalunya | 45 | España | 84 |
| 2 | Sebetralstat & Quality of Life in Breakthrough HAE | Daniel Soteres, MD | | 29 | Estados Unidos | 86 |
| 1 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 97 |
| 15 | Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence | Maui Derm | | 11 | Estados Unidos | 84 |